zoledronic acid has been researched along with trametinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bi, F; Dai, X; Tang, Q; Xia, H; Zhou, S | 1 |
| Ang, C; Antipin, Y; Bangi, E; Bhardwaj, A; Cagan, RL; Chen, R; Donovan, M; Gruszczynski, N; Hecht, C; Kim, S; Laspina, D; Lau, CY; Malyshev, D; Misiukiewicz, K; Moe, AS; Posner, MR; Rainey, H; Schadt, EE; Sebra, R; Selkridge, I; Smibert, P; Sung, M; Taik, P; Teague, AG; Uzilov, AV; Wilck, E; Yon, WJ; Yum, K | 1 |
3 other study(ies) available for zoledronic acid and trametinib
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.
Topics: A549 Cells; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Female; HCT116 Cells; HT29 Cells; Humans; Mevalonic Acid; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Mutation; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Pyridones; Pyrimidinones; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays; Zoledronic Acid | 2019 |
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Progression; Drosophila; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Genes, ras; Genomics; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Precision Medicine; Pyridones; Pyrimidinones; Zoledronic Acid | 2019 |